HUA MEDICINE
(HKEX: 2552)
Hua Medicine Ltd. provides drug discovery and development services. It offers drugs for diabetes and Central Nervous System disorders. Its products include Dorzagliatin HMS552, Dorzagliatin+Metformin, Dorzagliatin+DPPIV, Dorzagliatin+SGLT-2, Dorzagliatin+Insulin, Dorzagliatin+GLP-1 and mGLUR5 NAM. The company was founded by Chen Li on November 10, 2009 and is headquartered in Shanghai, China.
3.110 -
+0.030
(+0.97%)
Range
3.040 - 3.140
(3.29%)
Open
3.140
Previous Close
3.080
Bid Price
3.110
Bid Volume
('000)
15.5
Ask Price
3.120
Ask Volume
('000)
12
Volume
('000)
1,742.5
Value
5,372,716
Remark
-
Delayed prices. Updated at 29 Jan 2026 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
